
Private equity firms have quietly hijacked America’s veterinary industry, turning your beloved pet’s healthcare into a profit extraction machine that doubles bills while potentially compromising care.
Story Snapshot
- Private equity owns 30-50% of veterinary clinics, driving costs to double the rate of inflation
- Vets now routinely upsell unnecessary $5,000 procedures, exploiting emotional pet owners
- The veterinary lobby blocks telemedicine access in 20 states to protect their brick-and-mortar monopoly
- Dutch offers $100 annual video consultations as an alternative where legally permitted
The Private Equity Takeover Nobody Noticed
Wall Street discovered a goldmine hiding in plain sight: your unconditional love for your pets. Private equity firms systematically acquired between 30 and 50 percent of veterinary clinics across America, recognizing that pet owners represent the ultimate captive market. Unlike human healthcare, pet owners pay out of pocket, making price resistance minimal when emotions run high.
These financial engineers perfected a simple formula. Buy local veterinary practices, maintain the familiar faces and clinic names, then gradually ratchet up prices while cutting operational costs. The result? Veterinary care costs have skyrocketed at double the rate of inflation, creating a healthcare crisis that mirrors human medicine’s worst attributes.
The Upselling Epidemic Draining Your Wallet
Modern veterinary visits increasingly resemble high-pressure sales encounters rather than medical consultations. Routine checkups transform into elaborate upselling opportunities, with procedures like dental cleanings reaching astronomical $5,000 price points. These services often involve unnecessary anesthesia risks and procedures that previous generations of pets lived without for decades.
The emotional manipulation tactics border on predatory. Veterinarians present worst-case scenarios for minor ailments, leveraging pet owners’ guilt and fear to authorize expensive treatments. The result creates a perverse incentive structure where the sickest interpretation of symptoms generates the highest revenue, regardless of actual medical necessity.
Regulatory Capture Blocks Innovation
The American Veterinary Medical Association wields significant lobbying power to protect this lucrative status quo. Their primary weapon? Blocking telemedicine initiatives that could provide affordable alternatives to expensive clinic visits. Twenty states, including Texas, have banned veterinary telemedicine based on AVMA claims that remote consultations kill dogs.
This regulatory capture mirrors tactics used by other established industries threatened by technological disruption. The AVMA’s arguments against telemedicine crumble under scrutiny, particularly since many pet health issues require simple consultations rather than hands-on examination. Skin conditions, behavioral problems, and routine questions could easily be addressed remotely at fraction of current costs.
Dutch Challenges the Veterinary Cartel
Joe, who previously co-founded telehealth company Hims, experienced this veterinary price gouging firsthand when his corgi required expensive treatments. His frustration sparked Dutch, a telemedicine platform offering $100 annual subscriptions for video veterinary consultations. The service provides medications and professional advice where state regulations permit operation.
Dutch operates in states without restrictive telemedicine bans, demonstrating how technology could revolutionize pet healthcare affordability. The platform’s success highlights the artificial scarcity created by regulatory barriers rather than genuine medical limitations. Joe’s advocacy extends beyond business interests, launching savepuppies.com to challenge legislation protecting veterinary monopolies.


